Iron Deposition in Parkinson's Disease: A Mini-Review

Weiqi Zeng,Jin Cai,Lei Zhang,Qiwei Peng

DOI: https://doi.org/10.1007/s10571-024-01459-4

2024-02-24

Cellular and Molecular Neurobiology

Abstract:Iron deposition is crucial pathological changes observed in patients with Parkinson's disease (PD). Recently, scientists have actively explored therapeutic approaches targeting iron deposition in PD. However, several clinical studies have failed to yield consistent results. In this review, we provide an overview of iron deposition in PD, from both basic research and clinical perspectives. PD patients exhibit abnormalities in various iron metabolism-related proteins, leading to disruptions in iron distribution, transport, storage, and circulation, ultimately resulting in iron deposition. Excess iron can induce oxidative stress and iron-related cell death, and exacerbate mitochondrial dysfunction, contributing to the progression of PD pathology. Magnetic resonance imaging studies have indicated that the characteristics of iron deposition in the brains of PD patients vary. Iron deposition correlates with the clinical symptoms of PD, and patients with different disease courses and clinical presentations display distinct patterns of iron deposition. These iron deposition patterns may contribute to PD diagnosis. Iron deposition is a promising target for PD treatment. However, further research is required to elucidate the underlying mechanisms and their impacts on PD.

neurosciences,cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the mechanism of iron deposition in Parkinson's Disease (PD) and its impact on disease progression. Specifically, the article explores the following aspects:

1. **Relationship between abnormal iron metabolism and Parkinson's disease**: The article discusses that in PD patients, various proteins related to iron metabolism become abnormal, leading to disorders in iron distribution, transportation, storage, and circulation, and ultimately resulting in iron deposition. Excessive iron can induce oxidative stress and iron - dependent cell death, and exacerbate mitochondrial dysfunction, thereby promoting the development of PD pathology.

2. **Clinical significance of iron deposition**: Magnetic resonance imaging (MRI) studies have shown that the characteristics of iron deposition in the brains of PD patients vary. Iron deposition is related to the clinical symptoms of PD, and patients with different disease courses and clinical manifestations show different iron deposition patterns. These patterns may be helpful for the diagnosis of PD.

3. **Potential of iron deposition as a treatment target**: Although iron chelation therapy is theoretically a promising treatment method for PD, the results of some clinical trials are inconsistent. Therefore, further research is needed to clarify the underlying mechanisms of iron deposition and its impact on PD.

### Specific problem summary

- **Mechanism of iron deposition**: The article details the specific mechanisms of iron deposition, including abnormal iron distribution, abnormal transportation, abnormal storage, and the role of neuromelanin.

- **Abnormal iron distribution**: Research has found that the serum iron level in PD patients is decreased, while the iron content in the brain is increased, which may be due to changes in the blood - brain barrier (BBB) leading to iron transport disorders.

- **Abnormal iron transportation**: Pathological changes in α - synuclein affect iron homeostasis, leading to the ubiquitination of iron - transport proteins such as DMT1, and then affecting iron uptake and excretion.

- **Abnormal iron storage**: The level of iron - storage proteins such as ferritin in PD patients is decreased, resulting in an increase in unstable forms of iron, which in turn triggers more Fenton reactions.

- **Relationship between iron deposition and PD pathological progression**: Iron deposition promotes the progression of PD by inducing oxidative stress, iron - dependent cell death (such as ferroptosis), exacerbating α - synuclein pathological changes, causing mitochondrial dysfunction, and triggering neuroinflammation.

- **Relationship between iron deposition and clinical symptoms**: The degree of iron deposition is related to the progression of PD, and the iron deposition patterns in different brain regions are related to different clinical subtypes of PD, suggesting that iron deposition plays a role in the pathogenesis of different subtypes of PD.

In summary, this paper aims to comprehensively review the mechanism of action of iron deposition in PD, explore its impact on disease progression from the perspectives of basic research and clinical research, and evaluate the potential of iron deposition as a treatment target for PD.